Tahir Mahmood

MiNDERA Corp. develops non-invasive diagnostic tests targeting skin diseases. Its invasive micro-needle device extracts the whole transcriptome from the skin of patients, eliminating the need for clinical researchers to source skin biopsies. The company was founded by Tahir Mahmood, Philippe Nore, and Tobin Dickerson and is headquartered in South San Francisco, CA.

MiNDERA Corp. develops non-invasive diagnostic tests targeting skin diseases. Its invasive micro-needle device extracts the whole transcriptome from the skin of patients, eliminating the need for clinical researchers to source skin biopsies. The company was founded by Tahir Mahmood, Philippe Nore, and Tobin Dickerson and is headquartered in South San Francisco, CA.

MiNDERA Corp. develops non-invasive diagnostic tests targeting skin diseases. Its invasive micro-needle device extracts the whole transcriptome from the skin of patients, eliminating the need for clinical researchers to source skin biopsies. The company was founded by Tahir Mahmood, Philippe Nore, and Tobin Dickerson and is headquartered in South San Francisco, CA.

MiNDERA Corp. develops non-invasive diagnostic tests targeting skin diseases. Its invasive micro-needle device extracts the whole transcriptome from the skin of patients, eliminating the need for clinical researchers to source skin biopsies. The company was founded by Tahir Mahmood, Philippe Nore, and Tobin Dickerson and is headquartered in South San Francisco, CA.

MiNDERA Corp. develops non-invasive diagnostic tests targeting skin diseases. Its invasive micro-needle device extracts the whole transcriptome from the skin of patients, eliminating the need for clinical researchers to source skin biopsies. The company was founded by Tahir Mahmood, Philippe Nore, and Tobin Dickerson and is headquartered in South San Francisco, CA.